Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 475 to 524 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
483\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
484\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
485\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
486\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10908.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12491.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14513\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
487\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5277.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6042.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14505\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
488\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10872.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14483\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
489\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5281.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6044.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14457\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
490\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
15274.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13346.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14445\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
491\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5980.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6843.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14437\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
492\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5979.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6842.76\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14429\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
493\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5979.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6842.78\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
494\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
e2a-pbx1-associated protein; putative 47 kda protein. [source:refseq;acc:nm\_020140]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5979.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6842.72\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14428\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
495\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tetranectin precursor (tn) (plasminogen-kringle 4 binding protein). [source:swissprot;acc:p05452]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10804.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12363.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
496\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nostrin. [source:refseq;acc:nm\_052946]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
497\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eap30 subunit of ell complex. [source:refseq;acc:nm\_007241]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
498\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
liv-1 protein, estrogen regulated. [source:refseq;acc:nm\_012319]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
499\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
500\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate decarboxylase, 67 kda isoform (ec 4.1.1.15) (gad-67) (67 kda glutamic acid decarboxylase). [source:swissprot;acc:q99259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m1 chain (ec 1.17.4.1) (ribonucleotide reductase large chain). [source:swissprot;acc:p23921]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6913.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7907.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1437\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor suppressor p53-binding protein 2 (p53-binding protein 2) (53bp2) (bcl2-binding protein) (bbp). [source:swissprot;acc:q13625]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
15182.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13277.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14344\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enoyl-coa hydratase, mitochondrial precursor (ec 4.2.1.17) (short chain enoyl-coa hydratase) (sceh) (enoyl-coa hydratase 1). [source:swissprot;acc:p30084]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10067.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transduction protein cbl-b (sh3-binding protein cbl-b). [source:swissprot;acc:q13191]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6856.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7838.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14316\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3893.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4450.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6875.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7858.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
508\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7556.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8636.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14293\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
509\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7551.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8630.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14278\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5975.11\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6826.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14245\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek2 (ec 2.7.1.37) (nima-related protein kinase 2) (nima-like protein kinase 1) (hspk 21). [source:swissprot;acc:p51955]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10807.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12338.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14167\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7485.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8543.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14143\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7477\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8532.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1411\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-1 (e2f dimerization partner 1) (drtf1- polypeptide-1) (drtf1). [source:swissprot;acc:q14186]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3890.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4439.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14099\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-acetylgalactosamine kinase (ec 2.7.1.-) (galnac kinase) (galactokinase 2). [source:swissprot;acc:q01415]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4910.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5600.61\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14051\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucose 4-epimerase (ec 5.1.3.2) (galactowaldenase) (udp- galactose 4-epimerase). [source:swissprot;acc:q14376]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen [starch] synthase, muscle (ec 2.4.1.11). [source:swissprot;acc:p13807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9648.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10994.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13957\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
endo-beta-n-acetylglucosaminidase. [source:refseq;acc:nm\_022759]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9642.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10986.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13941\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u4/u6-associated rna splicing factor. [source:refseq;acc:nm\_004698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5390.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6142.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13937\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen [starch] synthase, liver (ec 2.4.1.11). [source:swissprot;acc:p54840]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9634.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10976.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aquaporin 4 (wch4) (mercurial-insensitive water channel) (miwc). [source:swissprot;acc:p55087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10640.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12117.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13887\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aquaporin 5. [source:swissprot;acc:p55064]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10640\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12117.6\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/